These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17226087)

  • 1. Does the rate of inappropriate therapy differ in implantable cardioverter-defibrillators from different manufacturers?
    Arya A; Haghjoo M; Emkanjoo Z; Dehghani MR; Sadr-Ameli MA
    J Interv Card Electrophysiol; 2006 Oct; 17(1):59-63. PubMed ID: 17226087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.
    von Gunten S; Schaer BA; Yap SC; Szili-Torok T; Kühne M; Sticherling C; Osswald S; Theuns DA
    Europace; 2016 May; 18(5):710-7. PubMed ID: 26609076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.
    Thijssen J; Borleffs CJ; van Rees JB; Man S; de Bie MK; Venlet J; van der Velde ET; van Erven L; Schalij MJ
    Heart Rhythm; 2012 Apr; 9(4):513-9. PubMed ID: 22094073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.
    Gold MR; Ahmad S; Browne K; Berg KC; Thackeray L; Berger RD
    Heart Rhythm; 2012 Mar; 9(3):370-7. PubMed ID: 21978966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing.
    Horlbeck FW; Mellert F; Kreuz J; Nickenig G; Schwab JO
    J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1336-42. PubMed ID: 22909190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.
    Biffi M; Ziacchi M; Bertini M; Sangiorgi D; Corsini D; Martignani C; Diemberger I; Boriani G
    Europace; 2008 Nov; 10(11):1288-95. PubMed ID: 18772164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole.
    Safak E; Schmitz D; Konorza T; Wende C; De Ros JO; Schirdewan A;
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):952-62. PubMed ID: 23692262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators.
    Hauser RG; Hayes DL; Epstein AE; Cannom DS; Vlay SC; Song SL; Tyers GF
    Heart Rhythm; 2006 Jun; 3(6):640-4. PubMed ID: 16731462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate ICD therapy: does device configuration make a difference.
    Soundarraj D; Thakur RK; Gardiner JC; Khasnis A; Jongnarangsin K
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):810-5. PubMed ID: 16922995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of implantable cardioverter defibrillator malfunctions during radiation therapy: neutrons as a probable cause of soft errors.
    Elders J; Kunze-Busch M; Smeenk RJ; Smeets JL
    Europace; 2013 Jan; 15(1):60-5. PubMed ID: 22848077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of intraoperative electrosurgery-induced implantable cardioverter defibrillator (ICD) detection.
    Friedman H; Higgins JV; Ryan JD; Konecny T; Asirvatham SJ; Cha YM
    J Interv Card Electrophysiol; 2017 Jan; 48(1):21-26. PubMed ID: 27665098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does change in device detected frequency of non-sustained or diverted episodes serve as a marker for inappropriate shock therapy? Analyses from the INTRINSIC RV and ALTITUDE-REDUCES Trials.
    Sullivan RM; Seth M; Berg K; Stolen KQ; Jones PW; Russo AM; Gilliam FR; Olshansky B
    Europace; 2014 May; 16(5):668-73. PubMed ID: 24489072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ICD: to replace or not to replace, this is the question. the ICD-downgrade + telemetry-upgrade-trial].
    Bänsch D; Kuck KH
    Herz; 2005 Nov; 30(7):630-4. PubMed ID: 16333590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator.
    Arya A; Haghjoo M; Dehghani MR; Alasti M; Alizadeh H; Kazemi B; Sadr-Ameli MA
    Heart Rhythm; 2005 Oct; 2(10):1094-8. PubMed ID: 16188588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.